Cryptococcemia in a patient with COVID-19: A case report

Mohamad Y Khatib; Amna A Ahmed; Said B Shaat; Ahmed S Mohamed; Abdulqadir J Nashwan

doi:10.1002/ccr3.3668

Cryptococcemia in a patient with COVID-19: A case report

Clin Case Rep. 2020 Dec 19;9(2):853-855. doi: 10.1002/ccr3.3668. eCollection 2021 Feb.

Authors

Mohamad Y Khatib¹, Amna A Ahmed¹, Said B Shaat², Ahmed S Mohamed¹, Abdulqadir J Nashwan^{1

3}

Affiliations

¹ Critical Care Medicine Department Hazm Mebaireek General Hospital (HMGH) Hamad Medical Corporation (HMC) Doha Qatar.
² Critical Care Medicine Department Hamad General Hospital (HGH) Hamad Medical Corporation (HMC) Doha Qatar.
³ University of Calgary in Qatar Doha Qatar.

Abstract

The authors urge clinicians to balance the use of Immunosuppressant drugs and tocilizumab for COVID-19 patients to avoid the development of infections like Cryptococcemia, leading to death within 30 days.

Keywords: COVID‐19; Cryptococcus neoformans; corticosteroids; cryptococcemia; tocilizumab.

Publication types

Case Reports